Flanagan et al v. Purdue Pharma L.P. et al
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
Ohio Northern District Court | |
Judge: | Dan Aaron Polster |
Case #: | 1:18-op-45405 |
Nature of Suit | 367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability |
Cause | 28:1332 Diversity-Personal Injury |
Case Filed: | Apr 11, 2018 |
Case in other court: | Tennessee Western, 2:18-cv-02194 |
Last checked: Friday Nov 08, 2019 5:31 PM EST |
Defendant
Actavis LLC
|
|
Defendant
Indivior, Inc.
|
Represented By
|
Defendant
Watson Pharmaceuticals, Inc.
|
|
Defendant
Watson Laboratories Inc.
|
|
Defendant
The Purdue Frederick Company Inc.
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
|
|
Defendant
Teva Pharmaceutical Industries Ltd.
|
|
Defendant
Purdue Pharma L.P.
|
|
Defendant
Purdue Pharma Inc.
|
|
Defendant
Ortho-Mcneil-Janssen Pharmaceuticals Inc.
|
|
Defendant
McKesson Corporation
|
Represented By
|
Defendant
Johnson and Johnson
|
|
Defendant
Janssen Pharmaceuticals Inc.
|
|
Defendant
Janssen Pharmaceutica Inc.
|
|
Defendant
Endo Pharmaceuticals Inc.
|
|
Defendant
Endo Health Solutions Inc.
|
|
Defendant
Cephalon Inc.
|
|
Defendant
Cardinal Health Inc.
|
|
Defendant
AmerisourceBergen Corporation
|
|
Defendant
Allergan PLC
|
|
Defendant
Actavis Pharma, Inc.
|
|
Plaintiff
Elena Flanagan
|
Represented By
|
Plaintiff
Darren Flanagan
|
Represented By
|
Plaintiff
Baby K.L.F.
|
Represented By
|
Plaintiff
David S. Walker
|
Represented By
|
Plaintiff
Sharon A. Walker
|
Represented By
|
Docket last updated: 04/08/2019 7:40 PM EDT |
Wednesday, March 21, 2018 | ||
1 | 1 COMPLAINT Flannagan against All Defendants (Filing fee $ 400), filed by All Plaintiffs. [Transferred from tnwd on 4/11/2018.] | |
Att: 1 Civil Cover Sheet, | ||
Att: 2 Civil Cover Sheet Attorney Attachment, | ||
Att: 3 Summons, | ||
Att: 4 Summons, | ||
Att: 5 Summons, | ||
Att: 6 Summons, | ||
Att: 7 Summons, | ||
Att: 8 Summons, | ||
Att: 9 Summons, | ||
Att: 10 Summons, | ||
Att: 11 Summons, | ||
Att: 12 Summons, | ||
Att: 13 Summons, | ||
Att: 14 Summons, | ||
Att: 15 Summons, | ||
Att: 16 Summons, | ||
Att: 17 Summons, | ||
Att: 18 Summons, | ||
Att: 19 Summons, | ||
Att: 20 Summons, | ||
Att: 21 Summons, | ||
Att: 22 Summons | ||
2 | 2 Judge Thomas L. Parker and Chief Magistrate Judge Diane K. Vescovo added. (jld) [Transferred from tnwd on 4/11/2018.] | |
3 | 3 NOTICE OF CASE TRACKING ASSIGNMENT PURSUANT TO LOCAL RULE 16.2: Pursuant to Local Rule 16.2, this case has been assigned to the Standard track. http://www.tnwd.uscourts.gov/pdf/content/LocalRules.pdf (jld) [Transferred from tnwd on 4/11/2018.] | |
4 | 4 NOTICE TO COMPLY WITH PLAN FOR ALTERNATE DISPUTE RESOLUTION (ADR): Pursuant to Section to 2.1 of the ADR Plan, all civil cases filed on or after Sept. 1, 2014, shall be referred automatically for ADR. For compliance requirements, refer to the ADR Plan at: http://www.tnwd.uscourts.gov/pdf/content/ADRPlan.pdf (jld) [Transferred from tnwd on 4/11/2018.] | |
5 | 5 NOTICE OF RIGHT TO CONSENT TO THE EXERCISE OF CIVIL JURISDICTION BY A MAGISTRATE JUDGE Pursuant to 28 U.S.C. 636(c), Fed.R.Civ.P.73, and Local Rule 72.1, this Court has designated the Magistrate Judges of this District to conduct trials and otherwise dispose of any civil case that is filed in this Court. Your decision to consent, or not consent, to the referral of your case to a United States Magistrate Judge for trial and entry of a final judgment must be entirely voluntary. The judge or magistrate judge to whom the case has been assigned will not be informed of your decision unless all parties agree that the case may be referred to a magistrate judge for these specific purposes. A less than unanimous decision will not be communicated by this office to either the judge or magistrate judge. The consent form is available on the courts website at https://www.tnwd.uscourts.gov/forms-and-applications.php (jld) [Transferred from tnwd on 4/11/2018.] | |
7 | 7 Summons Issued as to Purdue Pharma L.P.. The filer has been notified electronically that the summons has been issued, and the new docket entry reflects this. Upon notification of the new docket entry, the filer is to print the issued summons in order to effect service. (jld) [Transferred from tnwd on 4/11/2018.] | |
Thursday, March 22, 2018 | ||
6 | 6 DEFICIENCY NOTICE: Pursuant to Rule 5 of the Federal Rules of Civil Procedure, document1 Complaint,, filed by Baby K.L.F., Elena Flanagan, Darren Flanagan has been filed. However, the following deficiency has been found: it appears that all 19 summonses are being issued to PURDUE PHARMA L.P.. Please reissue to the correct defendants. Please refer to the[LINK:ECF User Manual] and[LINK:ECF Policies and Procedures] . The filer has one business day to correct the deficiency. 3/22/2018 (jld). [Transferred from tnwd on 4/11/2018.] | |
Monday, March 26, 2018 | ||
Civil Filing fee $ 400 paid, receipt number 0651-2752139. (Williams, MeLisa) [Transferred from tnwd on 4/11/2018.] | ||
Tuesday, April 10, 2018 | ||
8 | 8 CONDITIONAL TRANSFER ORDER (CTO-19) MDL No. 2804. Signed by Jeffery N. Luthi, Clerk of the Panel on 4/10/2018. (agj) [Transferred from tnwd on 4/11/2018.] | |
Wednesday, April 11, 2018 | ||
9 | 9 CASE TRANSFERRED IN from District of Tennessee Western. Case number 2:18-cv-02194. Original file, certified copy of transfer order and docket sheet received. |